From the killer barber of 'Sweeney Todd,' to Stephen Sondheim’s 'Assassins,' musicals have long dealt with morbid subject matter. Now a musical comedy based on Luigi Mangione, the 26-year-old man accused of gunning down the CEO of a healthcare company, is on its way to San Francisco. 'Luigi the Musical,' is billed as: 'A story of love, murder and hash browns,' is due to open in June at the Taylor Street Theatre. The show is described as a 'wildly irreverent, razor-sharp comedy that imagines the true story of Luigi Mangione, the alleged corporate assassin turned accidental folk hero.' The film features other famous characters, including convicted crypto-fraudster Sam Bankman-Fried, and former rap mogul, turned accused sex trafficker Sean 'Diddy' Combs.
News that CVS Health's Aetna is pulling out of the individual health insurance business, also known as Obamacare, could mean more insurers will follow if President Trump and his fellow Republicans in Congress cut health benefits. CVS' decision leaves about 1 million people in 17 states looking for new coverage in 2026. That's a fraction of the more than 24 million Americans who signed up for such coverage on the ACA exchanges last fall. But Republicans and the Trump White House are making moves to make it difficult on health insurers to sell Obamacare.
President Donald Trump has set his sights on the pharmaceutical industry to shoulder part of the cost of his tax cuts, pressing congressional Republicans to force drugmakers to accept lower prices on prescriptions covered by Medicaid.
The 2026 proposal is seeking to cut $33.3 billion in discretionary funding for HHS, representing a 26.2% reduction compared to the fiscal 2025 budget. This includes a $3.6 billion reduction in discretionary funding for the CDC, an $18 billion reduction for NIH, a $674 million reduction for CMS Program Management and a $240 million reduction for Administration for Strategic Preparedness and Response Hospital Preparedness Program.
Cigna has announced plans to launch a new specialized GLP-1 pharmacy called ENGUIDE from next month, as the obesity drug class popularized by Novo Nordisk and Eli Lilly becomes a key component of managed care firms' financials. GLP-1 drugs, which include Novo Nordisk's and Eli Lilly's weight loss drugs Wegovy and Zepbound, are a leading cost driver for managed care firms in a market expected to hit more than $100 billion by 2030.
The Cigna Group swung to a first quarter profit of $1.3 billion as the health insurer begins to gain control of rising medical costs and its Evernorth business continues to perform well. Cigna, which includes Evernorth Health Services and one of the nation's largest pharmacy benefit management companies, said first quarter net income was $1.3 billion, or $4.85 per share, compared with a net loss of $277 million, or 97 cents per share, in Q1 2024.